Patents Assigned to Abbott Diabetes Care Inc.
  • Publication number: 20240130647
    Abstract: Embodiments described herein include an analyte monitoring system including an application executing on a mobile device and an analyte monitoring system server. The application is configured to detect that a communication channel between the application and the analyte monitoring system server is non-responsive and taking actions in response or recommending options to correct the non-responsive communication channel. Techniques include receiving a notification from the analyte monitoring system server via a notification service server. In response to receiving the notification, output of a first connectivity alert is canceled. Also in response to receiving the notification, output of a second connectivity alert is scheduled to be output at expiration of a timer unless the mobile device receives a second notification from the analyte monitoring system server.
    Type: Application
    Filed: October 17, 2023
    Publication date: April 25, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: William Lee, Adam Vazquez, Steven Stratis
  • Patent number: 11967408
    Abstract: Method and system for providing diabetes management and insulin therapy based on substantially real time glucose monitoring system is provided.
    Type: Grant
    Filed: February 12, 2019
    Date of Patent: April 23, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventor: R. Curtis Jennewine
  • Patent number: 11963801
    Abstract: A system and method provides a glucose report for determining glycemic risk based on an ambulatory glucose profile of glucose data over a time period, a glucose control assessment based on median and variability of glucose, and indicators of high glucose variability. Time of day periods are shown at which glucose levels can be seen. A median glucose goal and a low glucose line provide coupled with glucose variability provide a view into effects that raising or lowering the median goal would have. Likelihood of low glucose, median glucose compared to goal, and variability of glucose below median provide probabilities based on glucose data. Patterns can be seen and provide guidance for treatment.
    Type: Grant
    Filed: June 11, 2018
    Date of Patent: April 23, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Erwin S. Budiman, Kenneth J. Doniger, Timothy C. Dunn, Nathan C. Crouther, Glenn Berman, Howard A. Wolpert
  • Patent number: 11957463
    Abstract: A method, apparatus, and a kit are capable of improving accuracy of CGS devices using dynamic outputs of continuous glucose sensors.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: April 16, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Boris P. Kovatchev, Christopher R. King
  • Patent number: 11954273
    Abstract: Systems, devices and methods for the management of glucose levels in the body of patient featuring user interface input mechanisms configured to provide haptic feedback to the user are provided.
    Type: Grant
    Filed: April 17, 2023
    Date of Patent: April 9, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Erwin S. Budiman
  • Patent number: 11950936
    Abstract: Methods, devices, systems, and kits are provided that buffer the time spaced glucose signals in a memory, and when a request for real time glucose level information is detected, transmit the buffered glucose signals and real time monitored glucose level information to a remotely located device, process a subset of the received glucose signals to identify a predetermined number of consecutive glucose data points indicating an adverse condition such as an impending hypoglycemic condition, confirm the adverse condition based on comparison of the predetermined number of consecutive glucose data points to a stored glucose data profile associated with the adverse condition, where confirming the adverse condition includes generating a notification signal when the impending hypoglycemic condition is confirmed, and activate a radio frequency (RF) communication module to wirelessly transmit the generated notification signal to the remotely located device only when the notification signal is generated.
    Type: Grant
    Filed: February 22, 2023
    Date of Patent: April 9, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Jean-Pierre Cole
  • Patent number: 11950875
    Abstract: Systems, devices and methods are provided for the integration of an analyte data reader and a medication delivery device. The integrated device can include a medication delivery portion, wireless communications circuitry configured to receive data indicative of an analyte level, and electronics. The integrated device can also include one or more near-field communication (NFC) antennas. Example embodiments of adverse condition protection features of the integrated device are also provided.
    Type: Grant
    Filed: April 19, 2022
    Date of Patent: April 9, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Jean-Pierre Cole, Cherie A. Bulala, Theodore J. Kunich, Xuandong Hua, Hila F. Ralston
  • Publication number: 20240108221
    Abstract: Methods and systems for providing therapy related data management are provided. The subject systems include one or more device components, and at least one memory storage unit and at least one data storage unit associated with such one or more device components. The device components may include one or more of an analyte monitoring system, a fluid delivery device and a remote terminal. The subject methods include use of the subject systems to optimize treatment of a patient.
    Type: Application
    Filed: September 29, 2023
    Publication date: April 4, 2024
    Applicant: Abbott Diabetes Care, Inc.
    Inventor: R. Curtis JENNEWINE
  • Publication number: 20240081700
    Abstract: Method and system for providing continuous calibration of analyte sensors includes calibrating a first sensor, receiving data associated with detected analyte levels from the first sensor, and calibrating a second sensor based on a predetermined scaling factor and data associated with detected analyte levels from the first sensor, is disclosed.
    Type: Application
    Filed: November 17, 2023
    Publication date: March 14, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Benjamin Jay Feldman
  • Patent number: 11918348
    Abstract: Medical devices configured for in vivo assays of one or more analytes can sometimes be problematic if left inserted in a tissue, such as skin, for an extended time. Certain medical device surface profiles may aid in alleviating this issue. Accordingly, medical devices may comprise a base surface having a tissue-facing surface profile defined thereon, and a sensor extending through the base surface and at least a portion of the tissue-facing surface profile. The tissue-facing surface profile deviates from the base surface, and the tissue-facing surface profile is also configured to undergo a change in shape, hardness, or a combination thereof after contacting a tissue for a length of time. A dynamic material may be present in at least a portion of the tissue-facing surface profile.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: March 5, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Jonathan McCanless, Hyun Brian Cho, Benjamin Feldman, Frank David Fujimoto
  • Patent number: 11918355
    Abstract: Apparatus, methods, and systems for detecting alcohol concentrations of an individual, and in particular in vivo alcohol concentrations of an individual. Alcohol sensing compositions include at least one alcohol-responsive active area comprising a concerted enzyme system having at least a first enzyme and second enzyme capable of acting in concert to facilitate the detection of alcohol. At least one of the enzymes in the concerted enzyme system is a ketoreductase.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: March 5, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Tianmei Ouyang, Ahmed Hisham Wali
  • Patent number: 11918782
    Abstract: Method and system for providing an integrated analyte monitoring system and on-body patch pump with multiple cannulas and a sensor combination is provided.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: March 5, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventor: R. Curtis Jennewine
  • Patent number: 11918356
    Abstract: A transcutaneous sensor configured to measure one or more physiological conditions of a patient. The transcutaneous sensor includes a substrate and first and second working electrodes on the substrate. The first working electrode includes a first active sensing area and the second working electrode includes a second active sensing area. The first active sensing area of the first working electrode is longitudinally offset along the substrate from the second active sensing area of the second working electrode.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: March 5, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventor: Benjamin Feldman
  • Publication number: 20240065586
    Abstract: A continuous analyte sensor system for monitoring a level of an analyte in a bodily fluid of a user. The system comprises a sensor electronics system and an analyte sensor. The sensor electronics system comprises a transceiver for transmitting outgoing signals including the data relating to the analyte level and for receiving incoming signals. The transceiver comprises an electromagnetic signal generating component having first and second signal feed points. The sensor electronics system operates in a first and/or second communication mode. In the first communication mode, the sensor electronics system supplies first outgoing signals to the first signal feed point. In the second communication mode, the sensor electronics system supplies second outgoing signals to the second signal feed point.
    Type: Application
    Filed: August 28, 2023
    Publication date: February 29, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Theodore John Kunich, Anthony Joseph San Nicolas
  • Publication number: 20240069009
    Abstract: Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
    Type: Application
    Filed: October 24, 2023
    Publication date: February 29, 2024
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Patent number: 11911151
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: October 6, 2022
    Date of Patent: February 27, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Thomas A. Peyser, Adam Heller
  • Patent number: D1015366
    Type: Grant
    Filed: July 12, 2022
    Date of Patent: February 20, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Yashesvini V. Ram, Claire A. Cunningham, Justin N. Williams, William Koo Lee
  • Patent number: D1021952
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: April 9, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Panganamala Ashwin Kumar, Andrew Revoltar, Pooja Hebbale
  • Patent number: D1021956
    Type: Grant
    Filed: June 21, 2022
    Date of Patent: April 9, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Panganamala Ashwin Kumar, Andrew Revoltar, Pooja Hebbale
  • Patent number: D1021957
    Type: Grant
    Filed: June 21, 2022
    Date of Patent: April 9, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Panganamala Ashwin Kumar, Andrew Revoltar